Suffolk County’s only multidisciplinary Lung Cancer Center follows guidelines aimed at preventing 22,000 deaths each year
Left to right, front row: Maureen Farrell, Sunday Campolo-Athans, NP, and Denise Vidal; and back row: April Plank, DNP, Thomas Bilfinger, MD, ScD, Co-Director, and Sajive Aleyas, MD, Co-Director.
The Lung Cancer Evaluation Center (LCEC) at Stony Brook University Cancer Center started a new lung cancer screening program on Sept. 30, which includes a low-dose radiation Chest CT scan for high-risk patients with the goal of early detection.
Up until now, the diagnosis of lung cancer has been made when patients have symptoms or through incidental findings on chest x-rays or CAT scans done for other reasons, according to the LCEC co-director. Since its inception in 2001, the LCEC has evaluated more than 5,000 patients with chest abnormalities. Up until now, the diagnosis of lung cancer has been made when patients have symptoms or through incidental findings on chest x-rays or CAT scans done for other reasons, said Sajive Aleyas, MD, an Interventional Pulmonologist, who serves as Co-Director of the Lung Cancer Evaluation Center.
The proposed federal guidelines recommend annual CT screening of current and former smokers, ages 55-80 with a history of smoking equivalent to a pack-a-day for 30 years or two packs a day for 15 years. The recommendation applies to those who have quit smoking in the past 15 years. Other candidates for screening include people ages 50-80 that have smoked a pack a day for 20 years and have one additional risk factor, such as radon exposure, occupational exposure, lung disease, history of cancer or family history of lung cancer.
The US Preventive Services Task Force believes the benefits to these smokers outweigh the risks involved in receiving the annual scans. About 22,000 of the United States’ nearly 160,000 annual lung cancer deaths could be prevented if doctors follow these screening guidelines, the Task Force said. Lung cancer found in its earliest stage is 80 percent curable, usually by surgical removal of the tumor.
“Patients have better outcomes, including the possibility of cure, when the diagnosis is made early,” Dr. Aleyas said. “Ultimately, these screenings will have significant effects on patient outcomes, and will save lives.”
The LCEC provides a multidisciplinary team, including a patient navigator, thoracic surgeon, interventional pulmonologist, oncologist, radiation oncologist, chest radiologist, nurse practitioners, and support staff — all specializing in lung cancer. “The team members at the Lung Cancer Evaluation Center have dedicated their careers to the diagnosis and treatment of lung cancer,” Dr. Aleyas said. “The center prides itself in prompt diagnosis and treatment, as well as psychological support.”
“Our service has the infrastructure in place to ensure appropriate screening and follow up,” said Thomas Bilfinger, MD, Thoracic Surgeon, who serves as Team Leader and Co-Director of the Lung Cancer Evaluation Center. The process involved will begin with initial telephone screening. Patients who are deemed appropriate for lung cancer screening will then undergo a comprehensive evaluation, which will include CT scan, review of the CT findings, explanation of the radiation exposure risk and smoking cessation counseling.
Lung cancer is the third most common cancer and the leading cause of cancer death in the United States. It claims the lives of more patients than breast, colon, prostate, and ovarian cancers combined. The most important risk factor for lung cancer is smoking, which results in approximately 80 percent of all lung cancer cases in the United States.
Although the prevalence of smoking has declined, approximately 37 percent of U.S. adults are current or former smokers. The incidence of lung cancer increases with age, occurring most commonly in people ages 55 years or older. Increasing age and cumulative exposure to tobacco smoke are the two factors most strongly associated with the occurrence of lung cancer. Lung cancer has a poor prognosis, and nearly 90 percent of persons with lung cancer die of the disease. However, early-stage non-small cell lung cancer (NSCLC) has a better prognosis and can be treated with surgical resection.
